CAERULEUS GENOMICS LTD
14481675Research and experimental development on biotechnology
CAERULEUS GENOMICS LTD
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
Bioescalator Innovation Building Old Road Campus, Roosevelt Drive Oxford OX3 7FZ England
Full company profile for CAERULEUS GENOMICS LTD (14481675), an active life sciences and medical technology company based in Oxford, England. Incorporated 14 Nov 2022. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2023–2025)
Cash in Bank
£594.79k
Net Assets
£921.56k
Total Liabilities
£32.49k
Turnover
N/A
Employees
13
Debt Ratio
3%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 30 Nov Year End | 2024 30 Nov Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Adam Paul Cribbs | Director | British | United Kingdom | 14 Nov 2022 | Active |
| Martin Philpott | Director | New Zealander | England | 14 Nov 2022 | Active |
| Peter Kirk Crane | Director | British | England | 14 Nov 2022 | Active |
See all 5 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
No PSC information available
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 23 Mar 2026 | Accounts | Annual accounts made up to 30 Nov 2025 | |
| 3 Dec 2025 | Confirmation Statement | Confirmation statement made on 27 Nov 2025 with updates | |
| 26 Nov 2025 | Accounts | Annual accounts made up to 30 Nov 2024 | |
| 5 Jun 2025 | Capital | Allotment of shares (GBP 176.8357) on 12 May 2025 | |
| 7 Jan 2025 | Officers | Change to director James Oliver Macfarlane on 6 Jan 2025 |
Annual accounts made up to 30 Nov 2025
Confirmation statement made on 27 Nov 2025 with updates
Annual accounts made up to 30 Nov 2024
Allotment of shares (GBP 176.8357) on 12 May 2025
Change to director James Oliver Macfarlane on 6 Jan 2025
Recent Activity
Latest Activity
Annual accounts made up to 30 Nov 2025
2 months ago on 23 Mar 2026
Confirmation statement made on 27 Nov 2025 with updates
6 months ago on 3 Dec 2025
Annual accounts made up to 30 Nov 2024
6 months ago on 26 Nov 2025
Allotment of shares (GBP 176.8357) on 12 May 2025
1 years ago on 5 Jun 2025
Change to director James Oliver Macfarlane on 6 Jan 2025
1 years ago on 7 Jan 2025